Jody discusses how politics and medicine are intertwined and how he deals with political issues in the context of individual patient encounters.

Medical errors are a common cause of harm to patients. In this episode of Critical Incident from Knowledgeable Provider, Jody recalls some of his own errors in the hope of encouraging all medical professionals to be honest and transparent about mistakes.

References:

1) Rodziewicz TL, Houseman B, Vaqar S, et al. Medical Error Reduction and Prevention. [Updated 2024 Feb 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499956/

2) Kimberly N. Williams, Crystal M. Fausett, Elizabeth H. Lazzara, Yuval Bitan, Anthony Andre, Joseph R. Keebler, Investigative approaches: Lessons learned from the RaDonda Vaught case, Human Factors in Healthcare, Volume 4, 2023, 100054, ISSN 2772-5014, https://doi.org/10.1016/j.hfh.2023.100054.

3) Newman-Toker DE, Nassery N, Schaffer AC, et alBurden of serious harms from diagnostic error in the USABMJ Quality & Safety 2024;33:109-120.

4) Makary M A, Daniel M. Medical error—the third leading cause of death in the US BMJ 2016; 353 :i2139 doi:10.1136/bmj.i2139

Cindy Hutchens describes her experiences living with SLE and her interactions with the healthcare system along the way.

Resources & References

1) Lupus Foundation of America (LFA)

2) The Lupus Book by Daniel Wallace

3) LFA Mid-South Chapter, Nashville, TN

4) LFA Walk to End Lupus Now

5) Jog NR, James JA. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Front Immunol. 2021 Feb 3;11:623944. doi: 10.3389/fimmu.2020.623944. PMID: 33613559; PMCID: PMC7886683.

6) Ünlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016 Jun;3(2):75-84. doi: 10.5152/eurjrheum.2015.0085. Epub 2015 Dec 29. PMID: 27708976; PMCID: PMC5042235.

7) Benlysta prescribing information

8) Rexulti prescribing information

9) Aplenzin prescribing information

No matter what area of medicine you work in, you are saving lives and improving your patients' quality of life. Sometimes that happens in dramatic fashion and sometimes you might not even notice it happening at all. In this episode, Jody recalls his experiences on the ambulance, in the hospital, and in the primary care clinic.

Dr. Todd Oyen returns to discuss his personal experience living with CMT. As it happens, September is CMT awareness month so this is the perfect time to share this special conversation.

Links:

1) Charcot Marie Tooth Association

2) Hereditary Neuropathy Foundation

3) Muscular Dystrophy Association

4) World Tang Soo Do Association

5) Oyen's North Alabama Tang Soo Do

6) Dr. Oyen's YouTube Channel

Apparently Jody doesn't know how to let it go. Listen as he rants about incidents from the distant past that still get under his skin. If you observe Festivus, consider this an early airing of grievances.

Sound effects by Voicemod.

The new PCAB Voquenza (vonoprazan) is being marketed as a superior alternative to PPI therapy for acid-related conditions (GERD with or without erosive esophagitis, H. pylori eradication). Are these two mechanisms of action really that different? Jody investigates.

References:

1) Prescriber information: https://www.phathompharma.com/wp-content/uploads/VOQUEZNA-tablets-Prescriber-Information.pdf

2) György Miklós Buzás, Dual acid-pump blocking as novel therapeutic approach to treatment of acid-related diseases, Medical Hypotheses, Volume 187, 2024, 111338, ISSN 0306-9877, https://doi.org/10.1016/j.mehy.2024.111338.

3) Katzka DA, Kahrilas PJ. Potassium-Competitive Acid Blocker Suppression of Gastric Acid in Erosive Esophagitis: Is Stronger and Longer Better? Gastroenterology. 2023 Jan;164(1):14-15. doi: 10.1053/j.gastro.2022.10.022. Epub 2022 Oct 28. PMID: 36341738.

4) Shin JM, Sachs G. Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep. 2008 Dec;10(6):528-34. doi: 10.1007/s11894-008-0098-4. PMID: 19006606; PMCID: PMC2855237.

5) Simadibrata DM, Syam AF, Lee YY. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2022 Dec;37(12):2217-2228. doi: 10.1111/jgh.16017. Epub 2022 Oct 26. PMID: 36181401; PMCID: PMC10092067.

6) Oshima T, Miwa H. Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases. J Neurogastroenterol Motil. 2018 Jul 30;24(3):334-344. doi: 10.5056/jnm18029. PMID: 29739175; PMCID: PMC6034668

During the week prior to Hurricane Ike making landfall in Texas, paramedics from all over the country helped evacuate patients from the storm's path. In this episode of Critical Incident from Knowledgeable Provider, Jody shares his personal experiences from that response.